Assessment of Flexible Ureteroscopy Residual Fragments
1 other identifier
observational
115
1 country
1
Brief Summary
Residual fragments of urinary calculi after flexible ureteroscopy (URF) can cause symptoms and additional surgeries. The assessment of residual fragments by imaging is not standardized. Computed tomography (CT) is the best way for evaluation of urinary stones, however, ionizing radiation from CT is deleterious. The aim of this study is to define which patients may avoid CT for evaluation of residual fragments after URF. 115 patients with \> 18 years old undergoing URF for kidney stone \< 20 mm or \< 15 mm in the lower calyx diagnosed by CT will be studied. The clinical evaluation of patients will be held by the same urologist in pre-operative consultation, 7 days after the procedure, 30 days after the procedure and 100 days after the procedure. The assessment of residual fragments will be made through TC, ultrasound and Kidney-bladder-ureter KUB 90 days after the procedure. The image methods for residual fragments assessment will be compared by Cochran Test and prediction of parameters to avoid CT will be made by multiple logistic regression, using IPSS 16.0, with significant level of 5%.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2015
CompletedStudy Start
First participant enrolled
March 1, 2015
CompletedFirst Posted
Study publicly available on registry
May 5, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedOctober 28, 2016
October 1, 2016
2 years
February 19, 2015
October 27, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
residual calculi > 2mm by CT
90 days
Secondary Outcomes (1)
complications by CT
90 days
Study Arms (1)
stone residuals
all patients are going to be submitted to the same intervention: CT, US, KUB
Interventions
Eligibility Criteria
Patients with symptomatic renal calculi
You may qualify if:
- Kidney calculi \> 5 mm and \< 20 mm or \< 15 mm in lower kidney calyx
You may not qualify if:
- Patients with kidney malformations, ureteral stenosis, previous ipsilateral kidney surgery, hydronephrosis, indwelling double J stent and contraindications for URF are going to be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Sao Paulo General Hospital
São Paulo, São Paulo, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandre Danilovic, MD
University of Sao Paulo General Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2015
First Posted
May 5, 2015
Study Start
March 1, 2015
Primary Completion
March 1, 2017
Study Completion
July 1, 2017
Last Updated
October 28, 2016
Record last verified: 2016-10